Sarcopenia - The search for emerging biomarkers

Alexander Kalinkovich, Gregory Livshits

Research output: Contribution to journalReview articlepeer-review

139 Scopus citations


Sarcopenia, an age-related decline in skeletal muscle mass and function, dramatically affects the life quality of elder people. In view of increasing life expectancy, sarcopenia renders a heavy burden on the health care system. However, although there is a consensus that sarcopenia is a multifactorial syndrome, its etiology, underlying mechanisms, and even definition remain poorly delineated, thus, preventing development of a precise treatment strategy. The main aim of our review is to critically analyze potential sarcopenia biomarkers in light of the molecular mechanisms of their involvement in sarcopenia pathogenesis. Normal muscle mass and function maintenance are proposed to be dependent on the dynamic balance between the positive regulators of muscle growth such as bone morphogenetic proteins (BMPs), brain-derived neurotrophic factor (BDNF), follistatin (FST) and irisin, and negative regulators including TGFβ, myostatin, activins A and B, and growth and differentiation factor-15 (GDF-15). We hypothesize that the shift in this balance to muscle growth inhibitors, along with increased expression of the C- terminal agrin fragment (CAF) associated with age-dependent neuromuscular junction (NMJ) dysfunction, as well as skeletal muscle-specific troponin T (sTnT), a key component of contractile machinery, is a main mechanism underlying sarcopenia pathogenesis. Thus, this review proposes and emphasizes that these molecules are the emerging sarcopenia biomarkers.

Original languageEnglish
Pages (from-to)58-71
Number of pages14
JournalAgeing Research Reviews
StatePublished - 1 Jul 2015
Externally publishedYes


  • Biomarker
  • Inflamm-aging
  • Muscle mass deterioration
  • Neuromuscular junction
  • Sarcopenia


Dive into the research topics of 'Sarcopenia - The search for emerging biomarkers'. Together they form a unique fingerprint.

Cite this